chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Dizziness after 3 weeks of initial covid shot with onset of tinnitus approximately 9 days after 2nd vaccination shot
Patient had redness across entire chest/upper back, swelling in hands, redness in hands, and having to place her hands in the air to get the circulation. Patient was given Benadryl IM and observed for 1 hour with vitals. Went home with a driver and states she is feeling better. Patient did report that this had happened during her previous covid injection, but started about 2 hours after the injection.
Warm, red, swollen 3x3cm x 8 1/2 cm. (L) deltoid region of vaccine.
Pt. had a red rash covering the anterior upper arm. He complained of muscle ache. Muscle was a little swollen. Pt. also complained of feeling tired. No redness or any kind of reaction at injection site. Told pt. to take BENADRYL and ADVIL before bed time.
Administered MMRV instead of MMR SQ. Patient also received a dose of Varicella SQ. Patient was notified of error on the same day at 12:15pm. Patient stated feels fine, she stated "it's okay." Corrective plan of action: will add lot numbers to salesforce prior to calling patient over for verification purposes. Double/triple check medication to be administered.
sore arm; her arm hurts but its getting worse; can feel a lump in that arm; This is a spontaneous report from a contactable consumer or other non hcp. A 41-years-old female patient received bnt162b2 (PFIZER-BIONTECH m-RNA COVID-19 VACCINE, solution for injection, Batch/Lot Number: ER8735) dose 2 via an unspecified route of administration, administered in Arm Left on 18May2021 as DOSE 2, SINGLE (Age at vacciantion 41-years-old) was for covid-19 immunisation. Medical history included migraine (Migraine). The patient's concomitant medications were not reported. The patient historical vaccine included bnt162b2 (PFIZER-BIONTECH m-RNA COVID-19 VACCINE, solution for injection, Batch/Lot Number: ER8736) via an unspecified route of administration on 27Apr2021 as DOSE 1, SINGLE was for covid-19 immunisation. Patient does not received any vaccine prior to the vaccinations and did not visited emergency Room or physician Office. On an unspecified date, the patient experienced sore arm (pain in extremity), her arm hurts but its getting worse (condition aggravated) (non-serious) and feel a lump in that arm (mass). On an unspecified, date with outcome of unknown. The outcome of the event pain in extremity outcome of not recovered.  No follow-up attempts are possible. No further information is expected.
Case previously recorded as MA2009-4085. Initial case report received from a nurse on 09 NOV 2009. A 6-month-old male patient was vaccinated with 0.5 mL FLUVIRIN (batch no. 1009225PA) i.m into the thigh on 09 NOV 2009. No adverse events were reported. Reference no: NA09-07868.
Low-grade fever; This spontaneous case was received on 08-Nov-2023 from a physician via agency (reference number: SEQW23-04137), reported by a physician (consumer) and concerned a female patient of unreported age.  The patient's medical history and concomitant medications were not reported.    On an unspecified date, the patient was vaccinated with influenza virus vaccine (brand not specified; dose, route of administration, anatomical location, and indication: not reported). The batch number was not reported.  On an unspecified date, an unknown amount of time after receiving influenza virus vaccine, the patient experienced low grade fever.  The outcome of the event was not reported.  The reporter did not provide a causality assessment.  Company comment: On an unspecified date, an unknown amount of time after receiving influenza virus vaccine, the patient experienced low grade fever. Causal role of the vaccine is unassessable, due to insufficient information about chronology and alternative aetiology.; Sender's Comments: On an unspecified date, an unknown amount of time after receiving influenza virus vaccine, the patient experienced low grade fever. Causal role of the vaccine is unassessable, due to insufficient information about chronology and alternative aetiology.
Inappropriate schedule of vaccine administered; No Adverse event; A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and NO ADVERSE EVENT (No Adverse event) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014F21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jul-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and NO ADVERSE EVENT (No Adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (A pharmacy staff reports that they inadvertently administered 51 doses of the monovalent vaccines) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered).    Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-704260 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704260: case
Tenderness in her left under arm; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (Tenderness in her left under arm) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced TENDERNESS (Tenderness in her left under arm). At the time of the report, TENDERNESS (Tenderness in her left under arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No relevant concomitant medications were reported. No treatment information was provided.    Reporter did not allow further contact.
Patient did not disclose she is prone to fainting after getting shots/blood drawn.  3-5 minutes after getting Janssen vaccine patient fainted in one of our aisles.  We had her sit down.  We gave her some water, kiwi strawberry, and a tootsie lollipop.  We monitored her for 15-20 minutes, then her mother took her out to parking lot.  We asked if they needed anything else while at our store, and just re-iterated that she is okay and is prone to fainting after any kind of shots/blood drawn.
Patient presented 2 days after receiving vaccines with redness at the site of injection. The redness covers an area about 2 inches by 3 inches. Patient states arm was very sore after receiving injection, progressively got worse, and the redness continued to become a bigger area about 24 hours after injection. 48 hours after injection and the redness is about the same size (has not continued to increase in size). Patient has not experienced this before.
Patient alleges the vaccine caused her to have a frozen shoulder. Pain and decrease mobility happened with the next 24 hours. It has continued the last two months, however is starting to improve.
This spontaneous report was received from a medical assistant, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported. On 31-MAY-2018, the patient was vaccinated with an improperly stored GARDASIL 9 for prophylaxis, lot #N025428 and expiration date 19-JUN-2020 (strength, dose, frequency and route of administration were not reported). No adverse effect was reported. The temperature of excursion was reported as below 30°F (-40°F), during a time frame of 4 hours and 7 minutes. There was no previous temperature of excursion reported. A digital data logger was involved. This is one of several reports received from the same reporter. Sender's Comments:  US-009507513-1806USA003811: US-009507513-1806USA007090: US-009507513-1806USA007091: US-009507513-1806USA007093.
Patient is a pleasant 83 y.o. female pediatrician with history of Sjogren's, hypothyroidism, hyperlipidemia, hypertension who had been at Hospital to get her Covid vaccine.  30 minutes after doing so she reports being in the lobby and about to walk upstairs and feeling fine. The next thing she knows she wakes up on the stairs with her nose and face bleeding surrounded by healthcare team. She denies any precipitating symptoms such as chest pain, shortness of breath, fevers dizziness, headache.  She reports feeling well otherwise in the last few days.  I did a thorough bony palpation exam including spine and he only point of tenderness besides on her face was the area above her right ankle. She does not have a history of syncope or collapse
Patient is a 7 year old female. Presents to the clinic with her mother for Pfizer Vaccination #1.   HPI Healthy female with no past medical history of chronic diseases, no known allergies complains of a burning sensation and itching in her Left upper arm approximately 12 minutes after obtaining Pfizer Covid Vaccination. Patient denies  metallic taste in mouth,  swelling of lips, face, tongue, respiratory distress, shortness of breath, wheezing,bronchospasam, stridor, headache, dizziness, flushing, vomiting, nausea, abdominal pain, urinary incontinence, itching eyes or nose, sneezing, clear watery eye  Discharge, and  nasal discharge.  Patient's mother denies vaccine reactions in the past.
This case was reported by a physician via call center representative and described the occurrence of joint pain in a 43-year-old male patient who received ENGERIX B adult. Co-suspect products included ENGERIX B adult. Previously administered products included ENGERIX B adult (1st dose in August 2013). Concurrent medical conditions included vitamin D deficiency, eczema, triglycerides high and genital warts. Concomitant products included MVI and vitamin D. In December 2013, the patient received the 2nd dose of ENGERIX B adult. In May 2014, the patient received the 3rd dose of ENGERIX B adult. In December 2013, an unknown time after receiving ENGERIX B adult and not applicable after receiving ENGERIX B adult, the patient experienced drug dose administration interval too long. In April 2015, the patient experienced vitamin B12 deficiency. In May 2015, the patient experienced joint pain, gastritis atrophic, fatigue, neck pain, shoulder pain, arthritis and numbness of extremities. The patient was treated with vitamin B12. On an unknown date, the outcome of the joint pain, vitamin B12 deficiency, gastritis atrophic, fatigue, neck pain, shoulder pain, arthritis, numbness of extremities and drug dose administration interval too long were unknown. The reporter considered the joint pain, vitamin B12 deficiency, gastritis atrophic, fatigue, neck pain, shoulder pain, arthritis and numbness of extremities to be possibly related to ENGERIX B adult. Additional details were provided as follows: In December 2013, the patient received 2nd dose of ENGERIX B, leading to lengthening of vaccination schedule. In May 2014, the patient receive the 3rd dose of ENGERIX B adult. In April 2015, the patient experienced vitamin B12 deficiency. In May 2015, the patient developed some symptoms which included neck and shoulder pain, arthritis, numbness in feet and fingers, generalized joint pain, atrophic gastritis and fatigue. The events were possibly related to vaccination with ENGERIX. No lot numbers or expiration dates of vaccines were available. The patient had been worked up for multiple sclerosis, but did not have it. No further information was available at the time of reporting.
I just didn't feel well. I had a massive headache and was kind of tired. I had been traveling a lot and I had gone to another area where the cases were high.  My colleague was ill as well. As soon as I flew back home I took a test which was positive. I became more congested, had sensitivity to light and a fever. I treated the symptoms with Tylenol, DayQuil and NyQuil along with a ton of water. I began to feel better by the 18th. I still feel congestion but the headache went away along with the fever.
diagnosed positive for COVID on 10/19/21; to hosp with worsening SOB, cough, nasal congestion, throat pain, loss of taste and smell; on NRB; condition worsened and pt required intubation; condition continued to deteriorate and pt died in the hosp
Case number PHEH2013US025229, is an initial spontaneous report received from a nurse on 03 Dec 2013. This report refers to an 11-year-old male patient. Past medical history and concomitant medication were not reported. He was vaccinated with FLUCELVAX (batch number: 009031A and expiry date: Jun 2014) at a dose pf 0.5 ml intramuscularly on 20 Nov 2013. No adverse event was reported following this administration error. Following an internal review on 18 Aug 2014, a significant correction was done for the information received on 03 Dec 2013: The BPI labeling of the event "Inappropriate age at vaccine administration" changed from listed to unlisted and added second indication as "Adult product administered to child.
I drew from a diluent vial that I assumed was left for me to use from the previous vaccinator in the morning. I drew up the vaccines from that vial and administered it to patient. Later on, I found out it was left from the day before, therefore the vaccines were expired. Our supervisor at the time was informed. A regulatory agency was called to make sure patients were safe. Patients will be contacted to inform them of the situation.
About 5 minutes after vaccine administration patient reported his arm felt like it went numb,  then patient lost consciousness. Patient was unconscious for approximately 20 seconds. Patient blood pressure was low and he was transported to local ER for evaluation as he had struck his head when he fell.
After a month of receiving the shot I have been having issues with my arm my muscle in my shoulder have been sore the pain shoots down my whole arm when I first got the pain I had to take pain killers from my mother just to be able to sleep and of of today I am still taking over the counter pain killers and still have pain I can't use my arm for long periods of time and still have moments of weakness i the arm that I got the shot.
This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown age and gender. The patient's pertinent medical history, drug reaction or allergies and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with improperly stored doses of VARIVAX (lot # M032495, expiry date: 06-JUL-2018; lot # M049127, expiry date: 15-DEC-2018) for prophylaxis reconstituted with properly stored sterile diluent (lot # and expiry date unknown). Dosing details and route of administration were not reported. On an unknown date, the vaccine was exposed to temperature of 5.2 F for 30 minutes. No adverse effects reported. No previous temperature excursions occurred. This case was reported because of a data logger. No product quality complaint (PQC) was reported. No further information to report. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1708USA013417.
Patient given 0.5 ml of H1N1 instead of the 0.25 recommended dose for children 6-35 mo of age.
3 rd  day after 2nd dose developed severe intestinal pain. Went to ER, had emergency surgery. Appendix removed. Diverticulitis blocking intestinal tract, removed. Colostomy. 3 days later he stopped breathing in hospital room, lung collapsed. Could not incubate. Had emergency traech. Airlifted to larger hospital, heart failure in flight. Result- heart enlarged to almost double, functioning at 50%. Also developed hypertension, both were new events for him.
Started with fever 99+, body aches, fatigue  less than 8 hours after shot with symptoms lasting over 36 hours .  Also started coughing about 10 hours after shot.  Dry continuous cough still going on 3 weeks past the vaccine.
patient reported to pharmacy with a bump and scab on arm. claims it was a reaction to flu vaccine
Client states 1-2 days after vaccination he started having numbness in his left arm. The numbness has traveled down his entire arm to the back of his hand. The numbness continues and has not resolved.
Pt checking out of office notified staff had rash at injection site and was itchy. Rash slightly warm to touch, flat lacey pattern noted. Dr notified and assessed. VSS, no difficulty breathing. Rash fading at time leaving.
pc from mom 3hrs p/vax pt reported had vomited x 3;had rash on lt arm @ inj site;t99.9;seen in ER, given phenergan for n,v & APAP;stated was probable vax rxn
Pregnant female received vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant female received vaccine) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 029A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 15-Sep-2020 and the estimated date of delivery was 09-Jul-2021. On 02-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant female received vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twentieth week of the pregnancy.  On 02-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant female received vaccine) had resolved.            Treatment drugs were not provided concomitant drugs were not provided.
bad runny nose and watery eyes; bad runny nose and watery eyes; sneezing; This spontaneous case was reported by a consumer and describes the occurrence of LACRIMATION INCREASED (bad runny nose and watery eyes), RHINORRHOEA (bad runny nose and watery eyes) and SNEEZING (sneezing) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LACRIMATION INCREASED (bad runny nose and watery eyes), RHINORRHOEA (bad runny nose and watery eyes) and SNEEZING (sneezing). At the time of the report, LACRIMATION INCREASED (bad runny nose and watery eyes), RHINORRHOEA (bad runny nose and watery eyes) and SNEEZING (sneezing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Left arm numbness and Migraine Headaches.  Treating migraines with perscription meds.  Not treating left arm at this time.  Hoping it
leg started to hurt; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "leg started to hurt".  Additional information: After received the first shot of pfizer covid vaccine, his leg started to hurt.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
patient received first Covid 19 vaccine, placed in observation after 15 minutes patient complained of feeling dizzy and felt hot. Vital signs taken, BP- 118/70, HR- 88, Sats 99%, offered water accepted and consuming , patient observed for another 15 mins for total of 30 mins, voices that she feels better with dizziness and feeling hot now gone.
3 months after second shot was unable to stand ( my job required me to stand 4-6 hours a day) had to quit because I couldn't . As time went by I ended up needing a cane to walk which walking and running was never a problem for me before the shots. My appetite diminished greatly. Depression was very heavy still is. I to this day cannot lie down to sleep because I cough all night. Energy is non existent
A mother reported that her 27 month old son received a 3rd dose of Hib-Titer vaccine, 3rd dose of Acel-Imune vaccine, Prevnar and hep B (manuf unk) on 12/5/00, when he was 6 months old. At 6 months of age, the infant "would not make eye contact and he would swing his hands around." The child was diagnosed with autism. The mother believes the cumulative exposure to thimerosol in the vaccines may be causing this condition. This case was considered serious since these events were considered medically important in this case. No additional info was available as of the date of this report.